BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 29109234)

  • 1. Maresin 1 Promotes Inflammatory Resolution, Neuroprotection, and Functional Neurological Recovery After Spinal Cord Injury.
    Francos-Quijorna I; Santos-Nogueira E; Gronert K; Sullivan AB; Kopp MA; Brommer B; David S; Schwab JM; López-Vales R
    J Neurosci; 2017 Nov; 37(48):11731-11743. PubMed ID: 29109234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-resolution lipid mediator maresin-1 ameliorates inflammation, promotes neuroprotection, and prevents disease progression in experimental models of multiple sclerosis.
    Zahoor I; Nematullah M; Ahmed ME; Fatma M; Mir S; Ayasolla K; Cerghet M; Palaniyandi S; Mao-Draayer Y; Rattan R; Giri S
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Agonist of the Protective Factor SIRT1 Improves Functional Recovery and Promotes Neuronal Survival by Attenuating Inflammation after Spinal Cord Injury.
    Chen H; Ji H; Zhang M; Liu Z; Lao L; Deng C; Chen J; Zhong G
    J Neurosci; 2017 Mar; 37(11):2916-2930. PubMed ID: 28193684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvin D3 Promotes Inflammatory Resolution, Neuroprotection, and Functional Recovery After Spinal Cord Injury.
    Kim J; Joshi HP; Sheen SH; Kim KT; Kyung JW; Choi H; Kim YW; Kwon SY; Roh EJ; Choi UY; Sohn S; Kim YH; Park CK; Kumar H; Han IB
    Mol Neurobiol; 2021 Jan; 58(1):424-438. PubMed ID: 32964315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of IL-6 signaling by MR16-1 inhibits reduction of docosahexaenoic acid-containing phosphatidylcholine levels in a mouse model of spinal cord injury.
    Arima H; Hanada M; Hayasaka T; Masaki N; Omura T; Xu D; Hasegawa T; Togawa D; Yamato Y; Kobayashi S; Yasuda T; Matsuyama Y; Setou M
    Neuroscience; 2014 Jun; 269():1-10. PubMed ID: 24657456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice.
    López-Vales R; Redensek A; Skinner TA; Rathore KI; Ghasemlou N; Wojewodka G; DeSanctis J; Radzioch D; David S
    J Neurosci; 2010 Mar; 30(9):3220-6. PubMed ID: 20203181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury.
    Zhang B; Bailey WM; Kopper TJ; Orr MB; Feola DJ; Gensel JC
    J Neuroinflammation; 2015 Nov; 12():218. PubMed ID: 26597676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis.
    Sánchez-Fernández A; Zandee S; Mastrogiovanni M; Charabati M; Rubbo H; Prat A; López-Vales R
    J Neuroinflammation; 2022 Feb; 19(1):27. PubMed ID: 35109863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms.
    Norimatsu Y; Ohmori T; Kimura A; Madoiwa S; Mimuro J; Seichi A; Yatomi Y; Hoshino Y; Sakata Y
    Am J Pathol; 2012 Apr; 180(4):1625-35. PubMed ID: 22417787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury.
    Chiu CW; Huang WH; Lin SJ; Tsai MJ; Ma H; Hsieh SL; Cheng H
    J Neuroinflammation; 2016 Jun; 13(1):154. PubMed ID: 27316538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescuing macrophage normal function in spinal cord injury with embryonic stem cell conditioned media.
    Guo L; Rolfe AJ; Wang X; Tai W; Cheng Z; Cao K; Chen X; Xu Y; Sun D; Li J; He X; Young W; Fan J; Ren Y
    Mol Brain; 2016 May; 9(1):48. PubMed ID: 27153974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 drives microglia and macrophages toward a phenotype conducive for tissue repair and functional recovery after spinal cord injury.
    Francos-Quijorna I; Amo-Aparicio J; Martinez-Muriana A; López-Vales R
    Glia; 2016 Dec; 64(12):2079-2092. PubMed ID: 27470986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats.
    Samantaray S; Das A; Matzelle DC; Yu SP; Wei L; Varma A; Ray SK; Banik NL
    J Neurochem; 2016 May; 137(4):604-17. PubMed ID: 26998684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MARESIN 1 PREVENTS LIPOPOLYSACCHARIDE-INDUCED NEUTROPHIL SURVIVAL AND ACCELERATES RESOLUTION OF ACUTE LUNG INJURY.
    Gong J; Liu H; Wu J; Qi H; Wu ZY; Shu HQ; Li HB; Chen L; Wang YX; Li B; Tang M; Ji YD; Yuan SY; Yao SL; Shang Y
    Shock; 2015 Oct; 44(4):371-80. PubMed ID: 26196844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy.
    Fleming JC; Bao F; Chen Y; Hamilton EF; Gonzalez-Lara LE; Foster PJ; Weaver LC
    J Neurosurg Spine; 2009 Nov; 11(5):575-87. PubMed ID: 19929361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine attenuates morphological deficits in a contusion model of spinal cord injury.
    Ravikumar R; Fugaccia I; Scheff SW; Geddes JW; Srinivasan C; Toborek M
    J Neurotrauma; 2005 Feb; 22(2):240-51. PubMed ID: 15716630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA-approved 5-HT
    Simmons EC; Scholpa NE; Schnellmann RG
    Exp Neurol; 2021 Jul; 341():113720. PubMed ID: 33848513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury.
    Huang WL; King VR; Curran OE; Dyall SC; Ward RE; Lal N; Priestley JV; Michael-Titus AT
    Brain; 2007 Nov; 130(Pt 11):3004-19. PubMed ID: 17901087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury.
    Simmons EC; Scholpa NE; Cleveland KH; Schnellmann RG
    J Pharmacol Exp Ther; 2020 Feb; 372(2):216-223. PubMed ID: 31776207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute administration of ucf-101 ameliorates the locomotor impairments induced by a traumatic spinal cord injury.
    Reigada D; Nieto-Díaz M; Navarro-Ruiz R; Caballero-López MJ; Del Águila A; Muñoz-Galdeano T; Maza RM
    Neuroscience; 2015 Aug; 300():404-17. PubMed ID: 26004679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.